Prime Medicine, Inc.PRMENASDAQ
Loading
Price-to-sales ratio
5Y CAGR
-17.0%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 111.44 | -4.0% |
| 2024 | 116.10 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 282.41 | - |
| 2019 | 0.00 | - |